What changed after the 2022 guidelines for pulmonary hypertension?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 37673774.
- Also identified by DOI 10.1016/j.ejim.2023.08.021.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
With an estimated prevalence of around 1%, pulmonary hypertension (PH) presents a relevant burden worldwide. In this review, we aim to give an overview of the novelties from the revised European Society of Cardiology (ESC) /European Respiratory Society (ERS) guidelines for the diagnosis and treatment of PH and their implication for the everyday clinical practice.
Medical subject headings
- Hypertension, Pulmonary
- Cardiology
- Hypertension